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Abstract. Antibiotic resistance is a global public health issue with several anthropogenic
drivers, including antibiotic consumption. Recent studies have highlighted that the re-
lationship between antibiotic consumption and antibiotic resistance is contextualised
by a variety of socioeconomic, cultural, and governance-related drivers of consumption
behaviour and contagion that have been underexamined. A potential complication for
research and policy is that measures of antibiotic consumption are often reliant on pre-
scribing or sales data which may not easily take into account the dynamics of community
consumption that include self-medication; for example, the preservation and use of
leftover medication or the obtaining of antibiotics without a prescription. This study
uses repeated cross-sectional survey data to fulfil two core aims: firstly, to examine the
individual-level and national-contextual determinants of self-medication among antibio-
tic consumers in European countries, and secondly, to examine the relationship between
self-medication behaviour and antibiotic resistance at the national level.
This study is particularly novel in its application of a multilevel modelling specification
that includes individual-level factors with both time-variant and persistent national cha-
racteristics to examine antibiotic consumption behaviours. The key findings of the study
are that survey respondents in countries with persistently higher levels of inequality,
burdens of out-of-pocket health expenditure, and corruption have an increased probability
of self-medicating with antibiotics. The study also highlights that overall levels of an-
tibiotic consumption and antibiotic self-medication do not correlate and are associated
heterogeneously with changes in different pathogen/antibiotic pairs. In summary, the
study emphasises that antibiotic stewardship and antibiotic resistance, whilst related by
biological mechanisms, are also inherently social issues. Attempts to improve antibio-
tic stewardship and address the challenge of antibiotic resistance should also attend to
structural challenges that underlie challenges to antibiotic stewardship in the community,
such as the effects of inequality and reduced access to healthcare services.
1 Introduction
Antibiotic resistance is a global public health problem that poses significant challenges
to modern medical infrastructure. The WHO (2019) lists antimicrobial resistance as one
of the top ten threats to global public health, alongside issues such as climate change
and vaccine hesitancy. In the UK Government Cabinet Office (2017, p. 8) National Risk
Register, antimicrobial resistance is listed alongside climate change as a long-term trend
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that is likely “to change the overall risk landscape,” making current risks more severe
and leading to the emergence of completely new risks.
Antibiotic resistance is the social manifestation of a biological process. The biological
process at the heart of antibiotic resistance is the evolution of evasion strategies by
bacteria to overcome chemical and environmental challenges, such as exposure to anti-
biotic medication (Wright 2007). Bacteria that survive exposure to antibiotics are then
able to grow and spread due to a lack of competition from other strains. There is an
inevitability to the evolutionary selection pressure that antibiotic consumption generates,
meaning it is important that antibiotics are used prudently in order to mitigate the speed
at which resistance develops. Understanding the relationship between unregulated off-
prescription antibiotic use, such as over-the-counter (OTC) sales or the use of leftover
antibiotics, and levels of antibiotic resistance is consequently important for both policy
and research agendas.
OTC sales of antibiotics are generally prohibited in EU Member States with the
exception of some specific antibiotics in some countries; nevertheless, antibiotics are
still accessible OTC or online in some Member States (Paget et al. 2017, Machowska,
Lundborg 2019). There are some healthcare-system drivers associated with the ability
to access antibiotics without a prescription, including a lack of enforcement of laws
prohibiting OTC sales of antibiotics and requirements to dispense whole pre-packaged
packages of antibiotics rather than specific quantities. Whilst the prevalence of resistance
has been shown to correlate with prescribed outpatient antibiotic use, it has also been
argued that the actual total consumption level includes self-medication which is not
accounted for in prescription statistics and whose burden may be underestimated by
sales figures (Grigoryan et al. 2006, 2010). For example, if an antibiotic course is not
completed in order to keep a supply of the medication for a second course, this could
lead to two sub-optimal courses. Patients’ having access to antibiotics prior to visiting a
healthcare professional can also drive regional variation in stewardship-related resistance
drivers, as evidenced in qualitative research into clinicians’ accounts of factors shaping
antibiotic prescribing decisions (Brookes-Howell et al. 2012).
This study has two central aims. Firstly, to examine the determinants of self-
medication among antibiotic consumers in European countries. This aim is addressed
through consideration of both individual-level characteristics and national-level contexts,
with an analysis approach that accounts for both time-variant and time-invariant contexts.
Secondly, to examine the relationship between self-medication behaviour and antibiotic
resistance at the national level.
These aims have implications not only for policies aimed at mitigating antibiotic
resistance through consumption behaviours, but also for research into this issue, since off-
prescription antibiotic use may not be captured by other measures, such as prescription
statistics. If the level of self-medication in a country is associated with variations in
antibiotic resistance measures between countries, this influence might not be captured
by measures that do not account for this type of community consumption. By utilising
a survey series that employs random probability sampling, this study is able to examine
the association between unregulated antibiotic consumption and antibiotic resistance
measures in a way that avoids the pitfalls associated with prescribing or sales data and
may illuminate this methodological challenge.
2 Literature
2.1 Drivers of Antibiotic Use and Self-Medication
There are many individual-level factors associated with self-medication using antibiotics
in Europe. Some of these determinants are related to individuals’ feelings of illness,
with multiple studies noting that self-medication is triggered in particular by upper
respiratory tract symptoms, fevers, common colds, sore throats, or conditions with similar
symptoms to a previous illness for which antibiotics were prescribed (Scicluna et al. 2009,
Skliros et al. 2010, Shabani, Redican 2018, Druică et al. 2021). More recently, research
in Australia has also found that COVID-19 pandemic-induced psychological distress
has been a trigger for preventive self-medication with antibiotics (Zhang et al. 2021).
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Further drivers are associated with the combination of healthcare professionals’ prescri-
bing practices (such as providing antibiotics without a prescription, over-prescribing,
and dispensing by packet rather than by number of pills), patient behaviour, and poor
access to healthcare, resulting in leftover antibiotics which are then stored for later use
(Eggermont et al. 2018, McNulty et al. 2006, 2007b, Grigoryan et al. 2007, Lescure et al.
2018, Guinovart et al. 2018, Machowska, Lundborg 2019). In summary, several of the
factors associated with self-medication relate to the individual experience of ill health in
combination with contextual and healthcare system influences.
Demographic and knowledge-related correlations with self-medication behaviours have
been inconsistent across studies in Europe. McNulty et al. (2006, 2007b), for example,
found in the UK that higher levels of knowledge about antibiotics were associated with
both higher course completion and also the storing of antibiotics for self-medication,
whilst other studies in Europe have found that lack of knowledge is associated with
greater propensity for self-medication (Horvat et al. 2017, Machowska, Lundborg 2019)
or had no significant bearing (Druică et al. 2021). Again, there are discrepancies in
European studies regarding the association of self-medication with demographic charac-
teristics. For example, whilst Pavydė et al. (2015) found that male, rural, and childless
respondents were more likely to self-medicate in Lithuania, McNulty et al. (2006) found
that younger and female respondents in the UK were more likely to hold leftover drugs.
In summary, at the individual-level self-medication has a complex set of determinants,
with heterogeneity among previous studies in European contexts.
More broadly, a number of socio-economic national characteristics have been associa-
ted with variations in antibiotic use, demonstrating the importance of understanding both
the contextual and individual factors associated with appropriate or otherwise antibio-
tic use. The quality of national governance, and in particular the level of corruption,
has been found to persistently associate positively with national levels of antibiotic
consumption (Rönnerstrand, Lapuente 2017, Mueller, Östergren 2016, Gaygisiz et al.
2017). Additionally, national cultural dimensions have repeatedly been associated with
levels of antibiotic consumption both appropriate and otherwise – especially Uncertainty
Avoidance, Masculinity, and Power Distance (Gaygisiz et al. 2017, Borg 2012, Deschepper
et al. 2008). Antibiotic use is more common in countries with lower tolerance for
uncertainty, an emphasis on cooperation and caring for vulnerable members of society,
and in countries where unequal distributions of power are less welcome. Cultural di-
mensions may explain why educational campaigns are not universally successful in all
countries, as the messaging of responsible antibiotic use may work against rather than
with the grain of national cultures established over long periods of time (Borg 2012).
These same cultural dimensions also influence the healthcare workers who gatekeep access
to antibiotics in most instances (Borg 2012). Intolerance for uncertainty for example, may
underpin practices like more defensive medicine on the part of healthcare professionals,
and unwillingness of the patient to wait out what could be a self-limiting cold and
refrain from requesting antibiotics. These cultural differences, if associated causally with
different patterns of antibiotic prescribing and consumption, would be indicative of the
need for international policymakers to locally tailor interventions by increasing focus on,
for example, on societal educational narratives or tightening regulatory mechanisms.
Variation in socio-economic and demographic factors has also been found to associate
with differences in national antibiotic consumption. Countries with higher average levels
of education among their populations tend to have lower levels of antibiotic consump-
tion, and the proportions of the population above 65 years of age and below 14 years of
age have both been positively associated with higher antibiotic consumption (Gaygisiz
et al. 2017, Blommaert et al. 2014). The relationship between variation in national
income measures and antibiotic consumption relative to other national indicators is not
completely clear in high-income settings. Klein et al. (2018) argue that Gross Domestic
Product (GDP) is primarily associated with antibiotic consumption in lower- and middle-
income countries, and that in higher-income countries economic growth is not a factor
driving variation in antibiotic consumption between countries. However, the amount
spent on healthcare expressed as a percentage of GDP has been positively associated
with antibiotic consumption (Blommaert et al. 2014). This suggests that in higher
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income settings such as those examined in this study, issues of culture and governance
described above including resource allocation for healthcare may be more important
for explaining variation in antibiotic consumption than general economic comparisons.
The question of resource allocation is particularly pertinent given the context of the
time period for this study, in which many countries in Europe implemented austerity
measures that impacted healthcare expenditure and access (Reeves et al. 2014, Stuckler
et al. 2017, ECDC 2013). Economic inequality, exacerbated by austerity measures, is
also associated with the distribution of health outcomes (Mackenbach et al. 2011, EC
2013b, Chauvel, Leist 2015, Detollanaere et al. 2018) and behaviours (Kino et al. 2017)
in Europe, including higher risk of infections among deprived groups and areas (ECDC
2013, Charani et al. 2021).
2.2 Social and Economic Drivers of Antibiotic Resistance
Antibiotic use is one among several drivers of levels of antibiotic resistance. Temporal
variation in antibiotic use has been shown to correlate positively with various antibiotic
resistances, such as the incidence of methicillin-resistant Staphylococcus aureus (MRSA)
in hospitals and the community (Lawes et al. 2015, Aldeyab et al. 2008, Lafaurie et al.
2012, Parienti et al. 2011), with sub-national spatial variation in antibiotic prescribing
also being shown to strongly positively correlate with MRSA bloodstream infections
(Andreatos et al. 2018). However, there are other societal factors beyond antibiotic
consumption that may compound or exacerbate the issue of antibiotic resistance by
maintaining environments in which antibiotic resistance is able to develop.
Policy proposals for addressing antibiotic resistance include awareness-raising and
the strengthening of antimicrobial stewardship alongside other measures such as the
development of ‘One Health’ surveillance, improving infection prevention and control,
and limiting the environmental exposure of antimicrobial resistant pathogens (Anderson
et al. 2019). In previous studies, national characteristics such as levels of development,
infrastructure quality, inequality, and levels of regulation have been found to explain
antibiotic resistance alongside, or occasionally with better fit than, levels of antibiotic
consumption (Collignon et al. 2015, 2018, Collignon, Beggs 2019, Savoldi et al. 2019,
Pärnänen et al. 2019, Hay et al. 2018, Bryce et al. 2016). These social and economic
conditions matter for the consideration of infection control, sanitary conditions, food
handling, waste treatment, water quality, and other areas that might influence the
contagion of antibiotic resistance rather than simply the development of resistance as
driven by antibiotic consumption. Collignon et al. (2018) in particular argue that the use
and overuse of antibiotics are drivers of the emergence and maintenance of antimicrobial
resistance, whilst other social, economic, and infrastructural factors contribute with
greater effect to the year-on-year changes in levels of resistance. This relationship is,
however, mediated by countries’ levels of economic development, for example with the
volume of antibiotic use only correlating with antibiotic resistance in more economically
developed regions rather than at a global scale (Collignon et al. 2018). Consequently,
when considering the relationship between national-level antibiotic consumption and
levels of antibiotic resistance, either cross-sectionally or longitudinally, it is necessary
to also consider the factors that may aid contagion as part of the analysis in order to
minimise the confounding of the consumption/resistance relationship by factors associa-
ted with greater propensity for contagion.
In summary, antibiotic consumption and antibiotic resistance are more than purely
biological issues: they are deeply embedded in personal, socio-economic, and cultural
contexts. Understanding variation in either specific antibiotic consumption behaviours
– such as self-medication in the case of this study – or antibiotic resistance requires an
appreciation of the human contexts in which these phenomena take place. By providing
evidence regarding the relationship between context and behaviour, this study may
inform both future research into these behaviours and future policymaking aiming to
address challenges to antibiotic stewardship in European contexts.
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3 Methods and Materials
3.1 Data sources
Survey data were from the Eurobarometer survey series. Eurobarometer surveys covering
European countries in 2009 (EC 2013a), 2013 (EC 2017), 2016 (EC 2019a), and 2018
(EC 2019b) posed questions about antibiotic use. Each survey sampled approximately
1,000 individuals per country (except in Cyprus, Luxembourg, and Malta, where 500
individuals are sampled per wave) using a random probability methodology and face-to-
face mode. The survey dataset covers 28 countries, but for the waves used in this study
Croatia (2013, 2016, 2018) was only sampled three times for the survey; Slovakia (2013,
2016, 2018) and Slovenia (2009, 2013, 2016) only had complete antibiotic resistance data
covering three years each, and Cyprus had no Hofstede Cultural Dimension data.
Country-level independent variable data were sourced from multiple locations. GDP
as a time-variant measure of economic prosperity (World Bank 2020a), Out-of-Pocket
health expenditure as a time-variant measure of the financial burden of healthcare for in-
dividuals (World Bank 2020b), and World Governance Indicator (World Bank 2020c)
data for a time-variant measure of corruption (Control of Corruption) were sourced
from World Bank datasets. Gini data as a time-variant measure of economic inequality
within countries were sourced from Eurostat (2019). Hofstede’s Cultural Dimensions
as time-invariant measures of cultural differences between countries were sourced from
Geert Hofstede (Hofstede 2015). The Hofstede Cultural Dimensions are one way of
capturing cultural factors at the national level, and they position countries relative to one
another along six statistically distinct dimensions of culture that describe relationships
to authority, conceptions of self, and ways of dealing with dilemmas of conflict (Hofstede
2011).
Antibiotic resistance variables were selected initially based on the World Health
Organisation’s global priority list of antibiotic-resistant bacteria (WHO 2017) and then
filtered based on the availability of data for the countries and years available in the survey
data. Final bacteria-antibiotic combinations used were Escherichia coli and Klebsiella
pneumoniae resistant to third-generation cephalosporins (3GCR E. coli and K. pneumo-
niae), MRSA, and carbapenem resistant Pseudomonas aeruginosa (CRPA). National-
level antibiotic resistance data were sourced from the ECDC (2020) Surveillance Atlas.
These country-level data were linked to the four-wave survey dataset by country and
wave for time-variant variables, and by country for the time-invariant variable. This
combined dataset included 25 sets of country-level data covering all four Eurobarometer
waves and two sets of country-level data covering three waves. Cyprus was excluded from
the analysis due to the lack of Hofstede Cultural Dimension data. The variables linked
to the survey dataset, which were all numerically continuous, are described in Table 1.
These descriptive statistics demonstrate not only that there are sizeable variations in
the persistent differences between European countries for these variables, but that there
are also a variety of different country-wave trajectories revealed by the ranges of the
differenced variables. The construction of these differenced variables is explained in the
‘Analysis’ section as part of the modelling approach.
3.2 Survey Variable Specification
The binary dependent variable used to examine self-medication in this study covered
respondents that reported having taken an antibiotic in the past 12 months, separating
respondents who obtained the last course of antibiotics they used from a medical prescrip-
tion or had them administered by a medical practitioner, and respondents who either
used leftover antibiotics from a previous course or obtained them without a prescrip-
tion. This variable was based on a question that was asked in all four Eurobarometer
waves used in this study, which directed participants to reflect on their behaviour within
the past year. This temporal bounding mitigates the possibility of recall issues that
have been previously demonstrated with regard to antibiotic consumption questions
(Anderson 2019) and improves the value of the variable as a temporal barometer for
behaviour. A limitation of this variable is that it does not capture the specific antibiotic
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































REGION : Volume 8, Number 2, 2021
A. Anderson 127
Note: R2 = 0.030
Figure 1: Antibiotic consumption against the level of self-medication among antibiotic
consumers for country-waves
being consumed, which does have bearing on the relationship between antibiotic con-
sumption and resistance development (Pouwels et al. 2019). The independent antibiotic-
related knowledge variables used in this study were derived from a set of four true/false
questions asked in all four surveys covering whether antibiotics kill viruses (correct =
false), whether antibiotics are effective against colds and flu (false), whether unnecessary
use of antibiotics makes them become ineffective (true), and whether taking antibiotics
often has side-effects such as diarrhoea (true). These were included as binary variables
in the analyses. Overall antibiotic consumption was calculated from the Eurobarometer
data to create an aggregate continuous measure for each country-wave to be controlled
in the regression model.
Figure 1 shows the relationship between the outcome variable (aggregated to the
country-wave level) and the aggregate overall consumption measure. A cluster-robust
linear regression of self-medication against total consumption (Estimate = 0.100, p =
0.166, R2 = 0.03), illustrated with a regression line in Figure 1, confirmed that these
measures were insignificantly correlated, with 3.0% of the variation in self-medication
among antibiotic consumers explained by the overall level of consumption in each country-
wave. This supports the rationale that self-medication may be a source of variation in
actual antibiotic consumption not captured by official sources such as prescription data.
3.3 Analysis
The aim of the analysis was firstly to examine individual- and national-level associa-
tions with self-medication behaviour and secondly to examine whether self-medication
behaviour was associated with four resistance measures from the WHO priority list.
Variable selection to control for known associations with antibiotic resistance – such
as correlates relating to contagion – was informed by the literature discussed above, and
bivariate cluster-robust regressions examining associations between national characteris-
tics and nationally-aggregated self-medication behaviour. In each of these regressions,
the clusters were countries, and the observations were individual years in each country.
Following these tests, a mixed-effects logistic regression model was fitted with self-
medication as the outcome variable. The model used a technique reported by Fairbrother
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(2014) (see also Schmidt-Catran, Fairbrother 2016) for the analysis of repeated cross-
sectional survey data, with a three-tier structure of respondents nested within country-
waves, nested within countries, to examine both time-variant and enduring national
effects. By using models with random intercepts, this study is able to analyse overall
associations across Europe through the regression coefficients for independent variables
(fixed effects) whilst allowing the mean of the coefficients to vary across country-waves
and countries. The regression model is specified by Fairbrother (2014) with X̄j as the
enduring cross-national effect, XtjM as the centred longitudinal component calculated
by subtracting Xtj from X̄j , and timetj as the temporal control (in this case Year), in
the following equation:
yitj = β0 + β1Xitj + β2XtjM + β3X̄j + β4timetj + uj + utj + ϵitj
In this study, a respondent from the UK in 2009, for example, would be nested
within the 2009 UK sample, which would itself be nested within the UK country level.
National-level effects were separated into enduring country-level differences calculated as
the median of available data for all years between 2009 and 2018 (X̄j), and differenced
effects within countries over time calculated as the value for a specific country-year (Xtj)
with the enduring median value for that country subtracted (XtjM ). This approach
models persistent differences between countries as well as differential trajectories in the
time period, acknowledging not only that respondents within countries are more likely to
be similar than between countries but that respondents sampled in the same year within
a country are more likely to be similar than in different years within the same country.
The exceptions to this separation were variables that were time-invariant for the study
period; specifically, the Hofstede cultural dimensions.
In summary, this modelling approach provides the ability to distinguish between
consistent differences between national contexts alongside differences in trajectories bet-
ween countries. For example, this approach could show firstly whether countries that are
persistently more economically equal are a significantly different context than those that
are less equal in the context of self-medication, and also whether countries that have had
large changes in inequality are a significantly different context than those that have seen
little change.
Further individual-level variables were included to control for country composition,
including: age interacted with gender, age respondents left education compared to the
median for their country-year, presence of children in the household, local geography,
and antibiotic-related knowledge. Interviewer-coded respondent cooperation was also
included, as this has been found to associated with antibiotic-related outcome variables
in other studies using survey data (Anderson 2020a) along with mode effects (Anderson
2020b). By controlling for individual-level variables within the analysis, including those
discussed in the Literature section and these protocol variables, the effects of demographic
distributions on antibiotic consumption behaviour are mitigated when analysing the
higher-level associations.
Following the mixed-effects modelling, cluster-robust multiple regression was used to
examine variation in country-level antibiotic resistance variables and their relationship
to the aggregated survey measures of antibiotic consumption and self-medication. These
models included the same socio-economic and cultural variables as the mixed-effects
models, with the addition of total antibiotic consumption and percentage of antibiotic
consumption that was self-medication aggregated for each wave for each country. The
aims of these models were to ascertain the relationship between national measures of
antibiotic resistance and, principally, the survey measure of antibiotic self-medication
used as an outcome variable in the mixed-effects models.
4 Results
The results of this study are broken down into multiple stages to address the two
key aims. The key model for the first aim (understanding the determinants of anti-
biotic self-medication behaviour across European countries) is a mixed-effects logistic
regression model accounting for individual-level respondent characteristics discussed in
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Table 2: Results of bivariate cluster-robust linear regressions of national characteristics
and the percentage of antibiotic self-medication among antibiotic consumers
Variable Estimate p R2 N
Year 0.233 0.002 0.03 111
Antibiotic Consumption (% Pop. in prev. 12 months) 0.100 0.166 0.03 111
Economic
GDP/capita (1,000s USD) -0.087 0.013 0.12 111
Gini (0-100) 0.581 0.000 0.26 111
Out-of-Pocket Health Expenditure/capita (10s USD) -0.040 0.154 0.06 111
Governance (-2.5-2.5)
Control of Corruption -2.989 0.000 0.29 111
Cultural Dimensions (0-112)
Power Distance 0.051 0.186 0.06 107
Individualism -0.096 0.036 0.15 107
Masculinity 0.005 0.822 0.00 107
Uncertainty Avoidance 0.057 0.045 0.09 107
Indulgence -0.086 0.005 0.15 111
Long-Term Orientation 0.026 0.401 0.01 107
Notes: Statistical significance (α = 0.05) denoted by asterisk.
the Literature section and available across all four waves of survey data, and time-variant
and invariant national contextual variables. National variable selection for this mixed-
effects model was informed by the Literature, along with cluster-robust linear regressions
of the aggregated self-medication outcome variable against the candidate national-level
variables. In particular, the cluster-robust regressions were used to determine which
of the six cultural dimensions were to be included alongside the other socio-economic
variables. This variable selection modelling is reported first, followed by the main model.
The second aim of the study is achieved through cluster-robust regression models with
national-level resistance measures as the outcomes predicted by a set of national-level
characteristics.
4.1 Bivariate Correlations: Self-Medication
Table 2 presents the results of bivariate cluster-robust regressions of national charac-
teristics for each country-wave on the percentage of antibiotic self-medication among
antibiotic consumers. The aim of these tests was to provide initial understanding of
these variables’ relationships with the self-medication outcome, and to determine which
cultural variables to include in the final model. National wealth represented by GDP per
capita (Est = -0.087, p = 0.013, R2 = 0.12) was negatively associated with the percentage
of antibiotic consumers reporting self-medication, whilst higher levels of income inequality
represented through the Gini coefficient (Est = 0.581, p <0.000, R2 = 0.26) were asso-
ciated positively with aggregate self-medication. There was no evidence for a significant
association between out-of-pocket health expenditure (Est = –0.040, p = 0.154, R2 =
0.06) and the level of self-medication. Countries with greater control of corruption (Est
= –2.989, p <0.000, R2 = 0.29) were correlated with lower levels of self-medication
among antibiotic consumers. Control of Corruption and the Gini coefficient had the
best fit measured by R2, accounting for 29% and 26% of the variation in aggregate
self-medication in their respective bivariate models. Among the cultural dimensions,
Uncertainty Avoidance (Est = 0.057, p = 0.045, R2 = 0.09) was positively associated
with levels of self-medication among antibiotic consumers, whilst the Individualism (Est
= –0.096, p = 0.036, R2 = 0.15) and Indulgence (Est = –0.086, p = 0.005, R2 = 0.15)
dimensions were negatively associated with self-medication. There was no evidence for
a significant association between Power Distance (Est = 0.051, p = 0.186, R2 = 0.06),
Masculinity (Est = 0.005, p = 0.822, R2 <0.01), or Long-Term Orientation (Est =
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0.026, p = 0.401, R2 = 0.01) and levels of self-medication. As described with Figure 1,
overall levels of antibiotic consumption in the survey samples was not correlated with
levels of self-medication among antibiotic consumers. Based on these results, only the
Uncertainty Avoidance, Individualism, and Indulgence cultural dimensions were included
in the mixed-effects model alongside the national socio-economic variables.
4.2 Multilevel Regression Results: Self-Medication
Table 3 contains the results for the full mixed-effects regression model predicting whether
an antibiotic consumer self-medicated or obtained antibiotics through a prescription.
Compared with the reference category (15–29 year-old female), antibiotic consumers in
the 30–41 (OR = 1.281, CI = 1.059 – 1.549) year-old female respondents category were
more likely to have self-medicated, whilst respondents in the 54–67 (OR = 0.792, CI =
0.647 – 0.968) and 67+ (OR = 0.477, CI = 0.379 – 0.599) year-old female category were
less likely to have self-medicated. Among males, those in the 15–29 (OR = 1.699, CI =
1.437 – 2.009) year-old category were almost 1.7 times as likely to have self-medicated
than 15–29 year-old females, whilst 30–41 (OR = 0.684, CI = 0.539 – 0.869), 54–67
(OR = 5.593, CI = 0.458 – 0.770), and 67+ (OR = 0.718, CI = 0.531 – 0.971) male
antibiotic consumers were less likely to have self-medicated. Antibiotic consumers who
had left education above the median age (OR = 1.121, CI = 1.018 – 1.236) for their
country-wave were marginally more likely to have self-medicated. Antibiotic consumers
who had two or more children under the age of 10 (OR = 0.797, CI = 0.672 – 0.946)
were less likely to have self-medicated than antibiotic consumers without children under
the age of 10, however antibiotic consumers with one child aged between 10 and 14
years (OR = 1.170, CI = 1.023 – 1.338) were more likely to have self-medicated than
consumers without children between these ages. Antibiotic consumers who correctly
answered that antibiotic are not useful for treating colds and influenzas (OR = 0.531, CI
= 0.47 – 0.588), that unnecessary use of antibiotics can lead to them becoming ineffective
(OR = 0.664, CI = 0.594 – 0.743), and that antibiotics cause side effects (OR = 0.837,
CI = 0.763 – 0.919) were all less likely to have self-medicated, though the strength of
the association differed between these questions. When contrasted with ‘Excellent’ co-
operators, antibiotic consumers who interviewers coded as having ‘Bad’ (OR = 1.647, CI
= 1.154 – 2.353) cooperation were more likely to have reported self-medicating behaviour.
Three national characteristics presented evidence for a significant association with
propensity to self-medicate among antibiotic consumers once other factors were controlled.
Antibiotic consumers in countries with persistently higher levels of income inequality (OR
= 1.070, CI = 1.026 – 1.115) were more likely to have self-medicated than obtained their
antibiotics through a prescription, however a higher rate of increase in inequality (OR =
0.931, CI = 0.871 – 0.995) was associated with being less likely to have self-medicated.
This clarifies the nature of the earlier finding that aggregate levels of self-medication
correlated with income inequality by separating this relationship into persistent country-
level variation and within-country temporal variation. The association of persistent diffe-
rences in inequality with higher levels of self-medication was further complemented by a
positive association between persistent differences in the amount of out-of-pocket health
expenditure per capita (OR = 1.009, CI = 1.000 – 1.018) and self-medication.
Additionally, respondents in countries perceived to have persistently higher levels of
control over corruption (OR = 0.606, CI = 0.413 – 0.888) were less likely to have self-
medicated in the previous 12 months. As with income inequality this finding clarifies the
earlier correlation by illustrating that, for this time period, persistent differences between
countries are more important for distinguishing between populations’ self-medication
behaviours than the rate at which change occurred within countries. There was no
further evidence in the model for other national contextual associations with individuals’
propensity for self-medication.
The significant results from this model are summarised in terms of their average
marginal effects (AMEs) in Figure 2. In contrast to the model results, age and gender are
not interacted in these AMEs. The marginal effects suggest that being a male respondent
(AME = 0.015, CI = 0.009 – 0.020) increased the chance of self-medication by 1.5%,
whilst being in the 42–53 (AME = –0.014, CI = –0.024 – 0.004), 54–67 (AME = –0.031,
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Table 3: Results for full mixed-effects logistic regression model predicting whether an
antibiotic consumer self-medicated or obtained antibiotics through a prescription
Self-Medication Mixed-Effects Model
Fixed Effects
Variable OR 2.5 97.5
Individual-Level Variables
Age*Gender (Reference: 15-29 year old Female)
30-41 Female 1.281* 1.059 1.549
42-53 Female 0.902 0.737 1.105
54-67 Female 0.792* 0.647 0.968
67+ Female 0.477* 0.379 0.599
15-29 Male 1.699* 1.437 2.009
30-41 Male 0.684* 0.539 0.869
42-53 Male 0.826 0.641 1.066
54-67 Male 0.593* 0.458 0.770
67+ Male 0.718* 0.531 0.971
Age Left Education (Reference: Below Median)
Age Left Education (Above Median) 1.121* 1.018 1.236
Still Studying 1.025 0.862 1.220
Children Under 10 years old in Household (Reference: None)
Children Under 10 (1) 0.950 0.835 1.080
Children Under 10 (2+) 0.797* 0.672 0.946
Children 10-14 years old in Household (Reference: None)
Children 10-14 (1) 1.170* 1.023 1.338
Children 10-14 (2+) 1.074 0.828 1.394
Local Geography (Reference: Rural)
Large Town 1.053 0.942 1.178
Small Town 1.059 0.953 1.178
Knowledge Questions (References: Incorrect or Don’t Know Response)
Antibiotics are ineffective against viruses 1.094 0.987 1.213
Antibiotics are ineffective against colds and flu 0.531* 0.479 0.588
Unnecessary use of antibiotics makes them ineffective 0.664* 0.594 0.743
Antibiotics cause side effects 0.837* 0.763 0.919
Respondent Cooperation (Reference: Excellent Cooperation)
Fair Cooperation 1.093 0.993 1.204
Average Cooperation 1.099 0.944 1.280
Bad Cooperation 1.647* 1.154 2.353
Country and Country-Wave Variables
Year 1.075 1.034 1.118
Total Antibiotic Consumption (% of Pop. ) (Enduring) 0.976 0.952 1.001
Total Antibiotic Consumption (% of Pop. ) (Differenced) 1.019 0.993 1.045
GDP/capita (USD 1,000s) (Enduring) 1.003 0.990 1.016
GDP/capita (USD 1,000s) (Differenced) 1.001 0.982 1.021
Gini (Enduring) 1.070* 1.026 1.115
Gini (Differenced) 0.931* 0.871 0.995
OOP/capita (USD 10s) (Enduring) 1.009* 1.000 1.018
OOP/capita (USD 10s) (Differenced) 0.995 0.983 1.007
Control of Corruption (Enduring) 0.606* 0.413 0.888
Control of Corruption (Differenced) 0.814 0.429 1.547
Individualism 0.993 0.984 1.003
Uncertainty Avoidance 0.993 0.986 1.001





Country-Year (107 levels) 0.263
Country (27 levels) 0.252
Notes: Statistical significance (α = 0.05) denoted by asterisk. N = 35, 332.
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Figure 2: Average marginal effects of significant variables in the mixed-effects regression
model, with 95% confidence intervals
CI = –0.041 – 0.021), and 67+ (AME = –0.048, CI = –0.0583 – 0.0376) age categories
decreased the change of self-medication by 1.4%, 3.1%, and 4.8% respectively. However,
as the model output in Table 3 highlights, the age quintiles do interact with gender
categories to produce more nuanced trajectories across the age groups, albeit with similar
interpretations. The marginal effects were generally comparable in size, for example with
overlapping confidence intervals for each of having two or more children under ten years
of age (AME = –0.012, CI = –0.021 – 0.004) reducing the change of self-medication by
1.2%, responding correctly regarding antibiotics being ineffective for treating colds and
flu (AME = –0.037, CI = –0.044 – 0.030) reducing the chance by 3.7%, unnecessary usage
of antibiotics rendering them ineffective (AME = –0.024, CI = –0.031 – 0.017) reducing
the change by 2.4%, and antibiotics causing side effects (AME = –0.010, CI = –0.016
– 0.005) reducing the change by 1%. Similarly, among positive associations there were
comparable magnitudes of AME for changes in year (AME = 0.004, CI = 0.002 – 0.007)
with the chance of a self-medication response increasing by 0.4% per year, and having
left education above the median age for the country-wave (AME = 0.007, CI = 0.001 –
0.011) increasing the chance of a self-medication response by 0.7%, and having one child
aged 10–14 (AME = 0.010, CI = 0.001 – 0.018) increasing the chance of self-medication
by 1%. Respondents categorised as bad co-operators (AME = 0.034, CI = 0.005 – 0.063)
were 3.4% more likely to have provided a self-medication response.
At the country level, the AMEs represent continuous rather than discrete variables.
For each increased point on the Gini coefficient representing a persistent difference bet-
ween countries (AME = 0.004, CI = 0.001 – 0.006) the likelihood of a self-medication
response increased by 0.4%, whilst for each point above the median Gini for the country
in the time period (AME = –0.004, CI = –0.008 – 0.000) the likelihood of self-medication
decreased by 0.4%. For each persistent 10USD increase in out-of-pocket health expen-
diture per capita (AME = 0.001, CI = 0.000 – 0.001) the likelihood of self-medication
increased by 0.1%, and for each increased point measuring Control of Corruption as
a persistent difference between countries (AME = -0.029, CI = –0.052 – 0.006) the
likelihood of self-medication decreased by 2.9%. The contrasting trajectories of the
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Figure 3: Predicted probabilities of self-medication for individuals in countries with
persisting differences in inequality, corruption, and out-of-pocket health expenditure with
95% confidence intervals
predicted probabilities for these significant contextual variables are illustrated in Figure
3.
4.3 Cluster-Robust Linear Regressions: Antibiotic Resistance
Table 4 presents the results of cluster-robust multiple regressions of national characteris-
tics on national-level antibiotic resistance measures for the selected antibiotic/pathogen
combinations. There were multiple patterns of association across the four measures,
evidencing a lack of homogeneity between the distributions of the antibiotic/pathogen
combinations. Overall antibiotic consumption was only associated with the MRSA (Est
= 0.633, p = 0.001) and 3GCR K. pneumoniae (Est = –0.670, p = 0.005) resistance
measures, being associated positively with MRSA and negatively with 3GCR K. pneu-
moniae. It is worth noting that in a bivariate regression, 3GCR K. pneumoniae was
positively and insignificantly associated (Est = 0.751, p = 0.08) with antibiotic con-
sumption and the association only became negative and significant after the introduction
of Control of Corruption, suggesting an element of confounding between consumption,
3GCR K. pneumoniae, and corruption measured at the national level. The proportion of
self-medication within overall antibiotic consumption however was positively associated
with CPRA (Est = 0.907, p = 0.013) only.
National wealth, represented as GDP/capita, was positively associated (Est = 0.398,
p = 0.001) with the level of 3GCR K. pneumoniae at the national level, and the level
of out-of-pocket health expenditure per capita was positively associated with 3GCR E.
coli (Est = 0.084, p = 0.023). Control of Corruption was a significant variable for
multiple resistance measures, with negative associations for CPRA (Est = –11.069, p
= 0.004), 3GCR E. coli (Est = –8.516, p <0.000), and 3GCR K. pneumoniae (Est =
–28.217, p <0.000). This means that countries perceived to have a better handle on
corruption tended to have lower levels of these resistance pairings, with the association
most pronounced in relation to 3GCR K. pneumoniae. In countries that were more
Indulgent there tended to be a higher level of MRSA (Est = 0.290, p = 0.026), whilst in
countries that were more prone to avoiding uncertainty there were lower levels of 3GCR
E. coli (Est = –0.110, p = 0.034).
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5 Discussion
Antibiotic consumption is one among a number of drivers of antibiotic resistance, and
the extent to which national variation in levels of antibiotic consumption are asso-
ciated with variation in levels of antibiotic resistance relative to other drivers (such
as contagion-related factors) has been the subject of recent research. Antibiotic use
measured through prescriptions or sales may not adequately capture consumption via
self-medication however, defined in this study as the practice of using leftover antibiotics
from previous prescriptions or otherwise obtaining antibiotics without a prescription.
Self-medication varies between countries and does not directly correlate with overall
antibiotic consumption, as demonstrated through the measures derived and correlated
in this study using random-probability survey samples of self-reported behaviour. The
explicit examination of associations between individual-level characteristics and macro-
level contexts and self-medication among antibiotic consumers is thus the first key con-
tribution of this study, followed by the examination of how total consumption and levels
of self-medication correlate with national measures of four different antibiotic/bacteria
combinations from the WHO priority list.
5.1 Self-Medication in Europe: Individual-Level Characteristics
Compliance with instructions for medication-taking is associated with several identified
factors, including age, patient-physician relationship, beliefs about medications, mis-
conceptions about disease conditions, experience and management of side-effects, and
individual personality traits (Foot et al. 2016, Aslani, Schneider 2014, Axelsson 2013).
The findings of this study support those of previous studies focusing on public antibiotic
stewardship behaviours. The finding that higher levels of education are associated with
a higher propensity for self-medicating behaviour among antibiotic consumers supports
previous research that has demonstrated associations between higher levels of education
and inappropriate stewardship behaviour (McNulty et al. 2007a, Shehadeh et al. 2012).
The finding that among antibiotic consumers, younger age groups of both male and
female genders have a higher propensity to self-medicate also supports previous studies
that have found that younger age groups are more likely to report inappropriate attitudes
and behaviours regarding antibiotic use (Anderson 2020a, Pechère et al. 2007, Napolitano
et al. 2013, Kardas et al. 2007).
This study suggests that specific aspects of knowledge about antibiotics and anti-
biotic resistance are relevant to self-medication propensity within European countries.
The raising of public awareness through education has been a key area of policy action
addressing antibiotic resistance, aiming to inform the public about how to take antibiotics
appropriately and the consequences of inappropriate antibiotic use through credible
professional sources (McParland et al. 2018, Price et al. 2018). Public health inter-
ventions commonly include knowledge-based components (McParland et al. 2018, Price
et al. 2018), though the relationship between individuals’ knowledge and their behaviour
with antibiotics has a mixed evidence base. Knowledge about antibiotics and antibio-
tic resistance has been associated in the literature with good stewardship attitudes and
behaviours (Anderson 2018, Kim et al. 2011, Jamhour et al. 2017, Horvat et al. 2017,
Vallin et al. 2016, Chan et al. 2012, McNulty et al. 2007b), as well as with negative
behaviours such as self-medication or retaining leftovers (McNulty et al. 2007b, Pan
et al. 2012). In addition to knowledge about antibiotics as a medication, meta-analyses
of adherence to medication have shown that individuals believing that the medication is
necessary for their health are more likely to follow medication-taking instructions, while
individuals that have strong concerns about the medication, such as beliefs about side-
effects, are less likely to follow instructions (Foot et al. 2016, Aslani, Schneider 2014,
Axelsson 2013, Horne et al. 2013).
This study contributes to these previous studies, having examined the relationship
between multiple aspects of individual-level knowledge about antibiotics. Specifically,
and with the strength of a large multi-country and multi-year survey dataset, this study
provides evidence that three specific aspects of knowledge about antibiotics and antibiotic
resistance are salient with regard to self-medication behaviour in Europe. Respondents
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that correctly responded that antibiotics cannot treat colds, that unnecessary use of
antibiotics exacerbates antibiotic resistance, and that antibiotic consumption commonly
comes with side-effects, were all less likely to have provided a self-medication response.
This might suggest that practical messaging linked to specific illness conditions may be
more effective for curbing self-medication behaviour than what may be more abstract
messages about not treating viral illness with antibiotics, for which comprehension in-
volves some academic understanding of biology. The association between knowledge of
the link between unnecessary antibiotic use and the development of antibiotic resistance
and lower propensity for self-medication was a positive sign that behaviour may be ass-
ociated with understanding of public health consequences. Similarly, the association
between knowing about antibiotics’ side-effects and lower propensity for self-medication
is also positive and may suggest that this knowledge makes antibiotics a less attractive
option for consumers that have not sought medical advice and may be in doubt over
whether antibiotics are necessary or not. However, this discussion must be caveated by
the cross-sectional nature of the data that gives these causal attributions a speculative
nature, since any causal association could go both ways between the outcome (self-
medication) and predictors (knowledge). For example, obtaining antibiotics via prescrip-
tion necessarily entails a visit to and interaction with a health professional who may
provide educational information, and this could also be a principal explanation for the
positive associations discussed above.
5.2 Self-Medication in Europe: Inequality and Corruption
This study suggests that there are some contextual factors relevant to self-medication
behaviour in Europe in addition to the above compositional factors. Inequality, as
measured by the Gini coefficient, has been found to be an illustrative measure of inequality
in the distribution of health outcomes (Mackenbach et al. 2011, EC 2013b, Chauvel, Leist
2015, Detollanaere et al. 2018) and modifiable health behaviours (Kino et al. 2017) in
Europe. This study suggests that antibiotic self-medication is part of the mosaic of poor
health outcomes and modifiable behaviours differentiating the health of countries with
persistently higher income inequality from those with lower inequality.
Increased income inequality is associated with greater precarity for individuals at the
low end of the income spectrum, referred to as, for example, the ‘precariat’ (Standing
2014, Greenstein 2020). In this study, persistent differences in income inequality bet-
ween European countries from 2009 to 2018 were associated with variation in levels
of self-medication behaviour, with people in countries experiencing persistently higher
levels of income inequality over this time period more likely to be associated with self-
medication behaviour. Alongside this, countries in which people bore persistently higher
burdens of out-of-pocket health expenditure also saw higher levels of self-medication
behaviour with antibiotics. During this time period, several countries implemented
austerity measures in response to the 2007/8 financial crisis that negatively impacted
upon funding, access to, and the provision of healthcare (Reeves et al. 2014, Stuckler
et al. 2017, ECDC 2013). Sargent, Kotobi (2017), for example, highlight that some
areas in France experienced “medical desertification” that was particularly damaging to
marginalized groups. There may consequently be several non-exclusive explanations for
why countries experiencing higher levels of inequality may also experience higher levels
of antibiotic self-medication among their population. Charani et al. (2021, p. 2), for
example, highlight that “low vaccination coverage persists in marginalized communities
in many settings” and that, “socioeconomic deprivation is a risk factor for many infectious
diseases including TB and meningococcal disease.” Economic precarity could be ass-
ociated with an inability to afford time away from work for illness, an inability to
pay for medication, and higher levels of ill health prompting antibiotic consumption,
whilst austerity measures that significantly affect vulnerable and deprived groups may
reduce access to healthcare services and be generative of leftover-retaining behaviours.
What remains unexplained, however, is why years with above average inequality over the
2009–2018 period tended to see lower levels of self-medication behaviour, or, to reverse
the trend: why years with below-average inequality tended to see higher levels of self-
medication behaviour. This area warrants further research using qualitative approaches
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that can provide more in-depth explanations of the relationship between economic preca-
rity and antibiotic self-medication in Europe. Whilst a definitive explanation cannot be
provided by this study, the results are suggestive that interventions to address antibiotic
self-medication in Europe should also aim to address structural economic factors that
may underly individuals’ self-medication behaviour.
This study also suggest that countries with greater control of corruption have lower
levels of self-medication among antibiotic consumers, which supports previous suggestions
that poorly controlled corruption is associated with a higher level of undocumented
antibiotic use (Collignon, Beggs 2019) in addition to general antibiotic use (Rönnerstrand,
Lapuente 2017, Mueller, Östergren 2016, Gaygisiz et al. 2017). As Collignon, Beggs (2019,
p. 6) articulate: “If corruption is poorly controlled, it is much more likely that there will
be antibiotic use that is undocumented and so antibiotic volumes used, and their effects,
will not be reflected in official figures.” This study directly supports this suggestion
by evidencing that countries with persistently higher levels of (perceived) corruption
are associated with greater propensity for self-medication – an undocumented form of
antibiotic consumption – among antibiotic consumers.
5.3 Social Correlates of Antibiotic Resistance
The findings of this study regarding the relationship between antibiotic consumption,
self-medication, and national resistance levels suggest that there are different impacts
across pathogen/antibiotic combinations for different aggregated levels of antibiotic-
related behaviour. A strong association has been shown between the use of carbapenems
to treat P. aeuruginosa infections and the development of resistance (Carmeli et al. 1999,
Lepper et al. 2002, Rossolini, Mantengoli 2005, Mladenovic-Antic et al. 2016), and in
particular the use of sub-inhibitory concentrations of antibiotics (Wright et al. 2013).
The finding in this study that high self-medication countries also tended to have higher
levels of CRPA suggests that the maintenance of CRPA levels is in part attributable to
poorly enforced regulation of antibiotic consumption, as members of the public are more
likely to have obtained the antibiotics they consumed in the past year off-prescription.
This is further supported by the negative association presented between the perception of
how well corruption is controlled in each country and the level of CRPA. These are only
correlations of aggregated data about antibiotic use broadly defined however, and do not
reveal the impact of specific classes of antibiotic. Indeed, the cross-sectional nature of the
data could also mean that any causal pathway operates in the reverse direction to that
suggested above, with higher levels of CRPA leading to higher demand for off-prescription
antibiotics.
Previous research has demonstrated relationships between antibiotic stewardship in-
terventions and the development of MRSA (Aldeyab et al. 2008, Lafaurie et al. 2012,
Lawes et al. 2015), as well as regionally aggregated antibiotic consumption and MRSA
bloodstream infection rates (Andreatos et al. 2018). This study provides support for these
previous studies by presenting a positive association between nationally aggregated levels
of antibiotic consumption and nationally-aggregated levels of MRSA. Previous studies
also demonstrate a positive association between antibiotic consumption, particularly
third-generation cephalosporins, and resistant K. pneumoniae (Joseph et al. 2015, Lom-
bardi et al. 2015, Yang et al. 2020). The present study would seem to contradict this
previous research by suggesting that there is a negative relationship between national
antibiotic consumption levels and the level of 3GCR K. pneumoniae. However, this
result is not necessarily anomalous, as a previous study by (Carlet et al. 2020) showed
that in France contrasting results were found regarding the relationship between anti-
biotic consumption (which was reduced following a public campaign) and some antibi-
otic resistance pairs. Carlet et al. (2020) showed that whilst resistance levels decreased
among S. aureus, the resistance of K. pneumoniae to third-generation cephalosporins
increased. This study echoes this with a positive association between overall consump-
tion and levels of MRSA and a negative association between overall consumption and
3GCR K. pneumoniae in the time period. Again, a clear caveat to this is that the survey-
based antibiotic consumption measures in this study do not account for the consumption
of specific classes of antibiotic or changing patterns of prescribing that might lead to
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higher or lower use of third-generation cephalosporins in different countries. However,
along with the association between levels of self-medication and CRPA, and the lack
of evidence for an association between antibiotic consumption (prescribed or otherwise)
and levels of 3GCR E. coli levels, these results do illustrate heterogeneity between pa-
thogen/antibiotic pairs in terms of their relationship to controlled or otherwise antibiotic
consumption broadly measured.
Importantly, this study included a number of socio-economic and cultural factors to
further contextualise the relationships between antibiotic consumption, self-medication,
and resistance measures. As with the antibiotic consumption measures, this study illus-
trates that there are varied factors associated with different resistance measures. Indeed,
3GCR E. coli levels were predominantly characterised in terms of socio-economic and
cultural factors, including out-of-pocket health expenditure per capita, corruption, and
cultural avoidance of uncertainty, rather than the level of consumption of antibiotics.
Corruption was a significant factor associated with levels of antibiotic resistance, more
so than either of the measures of antibiotic consumption used, supporting the argument
that poor governance (and in particular, high levels of corruption) is a significant barrier
to addressing antibiotic resistance (Collignon et al. 2015, 2018, Collignon, Beggs 2019).
Together these demonstrate that, socially, the challenge of ‘antibiotic resistance’ is a
broad church, and that addressing resistance between specific pathogens and classes of
antibiotic requires attention to the varied societal contexts that may aid the development
of various pathogenic ecologies, as well as the improvement of antibiotic stewardship.
5.4 Limitations
This study has multiple limitations that should be acknowledged. Whilst the modelling
approach distinguished between persistent and time-variant country-level differences, the
data used are cross-sectional in nature. This limits the potential for causal pathways
to be determined, and whilst these have been suggested in the context of existing
literature, alternative and potentially opposing pathways cannot be definitively ruled
out. Survey data themselves contain inherent limitations as a trade-off against large-scale
data collection and analysis. Specifically for this study, whilst associations with ‘antibio-
tic consumption’ and ‘self-medication’ can be determined, the motivations of individuals
and the specific experiences that underly these behaviours cannot be analysed in detail.
For example, the relationship between inequality and self-medication was explained with
a contextual rationale in this paper, but this area requires in-depth qualitative research
to fully understand the conditions that precipitate higher levels of self-medication in the
countries that have higher inequality. Furthermore, the survey-based measures of anti-
biotic consumption used in this study do not discriminate between prescribing policies
concerning the use of specific classes of antibiotics, which may influence patterns of
resistance between countries.
6 Conclusion
This study makes two key contributions to the literature. Firstly, it demonstrates that
antibiotic consumers in European countries with persistently higher levels of income
inequality, burdens of out-of-pocket health expenditure, and corruption are more likely
to consume antibiotics without a prescription than consumers in countries with lower
levels of inequality, out-of-pocket health expenditure, and corruption. This finding
is important, as measures of national antibiotic consumption between countries that
do not take into account off-prescription consumption may produce unreliable results
confounded by the level of inequality or out-of-pocket health expenditure or extent of
corruption in different countries. This study was able to distinguish, albeit broadly,
between antibiotic consumption and self-medication by using survey-based measures
rather than prescribing or sales data, and was able to distinguish between persistent and
time-variant differences between countries using a mixed-effects regression technique.
Secondly, the study has demonstrated that, whilst relationships between different pa-
thogen/antibiotic pairs and antibiotic consumption, self-medication, and socio-economic
and cultural factors are heterogeneous, socio-economic and cultural factors play an
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important role in explaining national variations in resistance. Whilst levels of corruption
appear to correlate with both self-medication and resistance levels, other factors like
cultural dimensions and economic variables presented different patterns across different
resistance pairs. Approaches to improve antibiotic stewardship in Europe by addressing
self-medication behaviours should take into account the structural factors that underlie
such behaviours, in addition to individual-level approaches like educational interventions.
Furthermore, these approaches should take into account that antibiotic resistance is not
simply driven by antibiotic consumption, but is contextualised by social, economic, and
cultural environments.
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